Sensus Healthcare Inc (SRTS)
5.30
-0.08
(-1.49%)
USD |
NASDAQ |
Jun 14, 16:00
5.285
-0.02
(-0.28%)
After-Hours: 20:00
Sensus Healthcare Research and Development Expense (TTM): 3.508M for March 31, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | 3.508M |
| December 31, 2023 | 3.68M |
| September 30, 2023 | 4.161M |
| June 30, 2023 | 3.824M |
| March 31, 2023 | 3.829M |
| December 31, 2022 | 3.459M |
| September 30, 2022 | 3.407M |
| June 30, 2022 | 3.405M |
| March 31, 2022 | 3.503M |
| December 31, 2021 | 3.436M |
| September 30, 2021 | 3.173M |
| June 30, 2021 | 3.37M |
| March 31, 2021 | 3.593M |
| December 31, 2020 | 4.157M |
| September 30, 2020 | 4.264M |
| June 30, 2020 | 4.890M |
| March 31, 2020 | 5.677M |
| Date | Value |
|---|---|
| December 31, 2019 | 6.418M |
| September 30, 2019 | 6.953M |
| June 30, 2019 | 7.098M |
| March 31, 2019 | 6.728M |
| December 31, 2018 | 6.260M |
| September 30, 2018 | 6.471M |
| June 30, 2018 | 6.259M |
| March 31, 2018 | 5.853M |
| December 31, 2017 | 5.491M |
| September 30, 2017 | 4.523M |
| June 30, 2017 | 3.412M |
| March 31, 2017 | 2.666M |
| December 31, 2016 | 1.824M |
| September 30, 2016 | 1.431M |
| June 30, 2016 | 1.400M |
| March 31, 2016 | 1.320M |
| December 31, 2015 | 1.467M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
3.173M
Minimum
Sep 2021
7.098M
Maximum
Jun 2019
4.290M
Average
3.752M
Median
Research and Development Expense (TTM) Benchmarks
| Perspective Therapeutics Inc | 24.91M |
| Retractable Technologies Inc | 0.5937M |
| Xtant Medical Holdings Inc | 1.689M |
| Asensus Surgical Inc | 34.98M |
| Catheter Precision Inc | 0.272M |